NCT02838589View on ClinicalTrials.gov

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Stroke
Interventions
DRUG

Byetta

Single dose of subcutaneous injection of 5 μg exenatide (Byetta).

DRUG

Isotonic saline

Single dose of subcutaneous injection of 20 μL isotonic saline (placebo).

Trial Locations (1)

2730

Department of Neurology, Herlev-Gentofte Hospital, Herlev

All Listed Sponsors
lead

Christina Kruuse

OTHER

NCT02838589 - The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers | Biotech Hunter | Biotech Hunter